BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28280747)

  • 21. Inactivation of Genes by Frameshift Mutations Provides Rapid Adaptation of an Attenuated Vaccinia Virus.
    Senkevich TG; Zhivkoplias EK; Weisberg AS; Moss B
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32669330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of In Vivo Expression of Genes Delivered by Self-Amplifying RNA Using Vaccinia Virus Immune Evasion Proteins.
    Beissert T; Koste L; Perkovic M; Walzer KC; Erbar S; Selmi A; Diken M; Kreiter S; Türeci Ö; Sahin U
    Hum Gene Ther; 2017 Dec; 28(12):1138-1146. PubMed ID: 28877647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C7L family of poxvirus host range genes inhibits antiviral activities induced by type I interferons and interferon regulatory factor 1.
    Meng X; Schoggins J; Rose L; Cao J; Ploss A; Rice CM; Xiang Y
    J Virol; 2012 Apr; 86(8):4538-47. PubMed ID: 22345458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative Temporal Proteomic Analysis of Vaccinia Virus Infection Reveals Regulation of Histone Deacetylases by an Interferon Antagonist.
    Soday L; Lu Y; Albarnaz JD; Davies CTR; Antrobus R; Smith GL; Weekes MP
    Cell Rep; 2019 May; 27(6):1920-1933.e7. PubMed ID: 31067474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The amino terminus of the vaccinia virus E3 protein is necessary to inhibit the interferon response.
    White SD; Jacobs BL
    J Virol; 2012 May; 86(10):5895-904. PubMed ID: 22419806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A loss of function analysis of host factors influencing Vaccinia virus replication by RNA interference.
    Beard PM; Griffiths SJ; Gonzalez O; Haga IR; Pechenick Jowers T; Reynolds DK; Wildenhain J; Tekotte H; Auer M; Tyers M; Ghazal P; Zimmer R; Haas J
    PLoS One; 2014; 9(6):e98431. PubMed ID: 24901222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccinia Virus Arrests and Shifts the Cell Cycle.
    Martin CK; Samolej J; Olson AT; Bertoli C; Wiebe MS; de Bruin RAM; Mercer J
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35216024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses.
    Waibler Z; Anzaghe M; Ludwig H; Akira S; Weiss S; Sutter G; Kalinke U
    J Virol; 2007 Nov; 81(22):12102-10. PubMed ID: 17855554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccinia virus infection attenuates innate immune responses and antigen presentation by epidermal dendritic cells.
    Deng L; Dai P; Ding W; Granstein RD; Shuman S
    J Virol; 2006 Oct; 80(20):9977-87. PubMed ID: 17005676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlates between host and viral transcriptional program associated with different oncolytic vaccinia virus isolates.
    Reinboth J; Ascierto ML; Chen NG; Zhang Q; Yu YA; Aguilar RJ; Carretero R; Worschech A; Zhao Y; Wang E; Marincola FM; Szalay AA
    Hum Gene Ther Methods; 2012 Oct; 23(5):285-96. PubMed ID: 23131031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic-dependent expression of early transcription factor subunits leads to stringent control of vaccinia virus replication.
    Hagen CJ; Titong A; Sarnoski EA; Verardi PH
    Virus Res; 2014 Mar; 181():43-52. PubMed ID: 24394294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antagonizing activity of vaccinia virus E3L against human interferons in Huh7 cells.
    Arsenio J; Deschambault Y; Cao J
    Virology; 2008 Jul; 377(1):124-32. PubMed ID: 18502465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A role for vaccinia virus protein C16 in reprogramming cellular energy metabolism.
    Mazzon M; Castro C; Roberts LD; Griffin JL; Smith GL
    J Gen Virol; 2015 Feb; 96(Pt 2):395-407. PubMed ID: 25351724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of DAI-dependent necroptosis by the Z-DNA binding domain of the vaccinia virus innate immune evasion protein, E3.
    Koehler H; Cotsmire S; Langland J; Kibler KV; Kalman D; Upton JW; Mocarski ES; Jacobs BL
    Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11506-11511. PubMed ID: 29073079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myxoma Virus dsRNA Binding Protein M029  Inhibits the Type I IFN-Induced Antiviral State in a  Highly Species-Specific Fashion.
    Rahman MM; McFadden G
    Viruses; 2017 Feb; 9(2):. PubMed ID: 28157174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification from diverse mammalian poxviruses of host-range regulatory genes functioning equivalently to vaccinia virus C7L.
    Meng X; Chao J; Xiang Y
    Virology; 2008 Mar; 372(2):372-83. PubMed ID: 18054061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccinia virus E3 protein prevents the antiviral action of ISG15.
    Guerra S; Cáceres A; Knobeloch KP; Horak I; Esteban M
    PLoS Pathog; 2008 Jul; 4(7):e1000096. PubMed ID: 18604270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. siRNA targeting vaccinia virus double-stranded RNA binding protein [E3L] exerts potent antiviral effects.
    Dave RS; McGettigan JP; Qureshi T; Schnell MJ; Nunnari G; Pomerantz RJ
    Virology; 2006 May; 348(2):489-97. PubMed ID: 16480752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of cellular genes induced in human cells after activation of the OAS/RNaseL pathway by vaccinia virus recombinants expressing these antiviral enzymes.
    Domingo-Gil E; González JM; Esteban M
    J Interferon Cytokine Res; 2010 Mar; 30(3):171-88. PubMed ID: 20038200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccinia virus F5 is required for normal plaque morphology in multiple cell lines but not replication in culture or virulence in mice.
    Dobson BM; Procter DJ; Hollett NA; Flesch IE; Newsome TP; Tscharke DC
    Virology; 2014 May; 456-457():145-56. PubMed ID: 24889234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.